Replies to post #9262 on Rich Pharmaceuticals Inc. (fka RCHA)

[biotechzeek]

Do you even read? Look at the bottom:

"10/13/2014
Richard L. Chang (Seller)
Rich Pharmaceuticals (Buyer)
Rich Pharmaceuticals is purchasing IP rights related to using RP-323 to treat Hodgkin's lymphoma from Richard L. Chang Holdings"